News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
259 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18555)
Month
January (2722)
February (2862)
March (3369)
April (3287)
May (3419)
June (3649)
July (3258)
August (3461)
September (3585)
October (3789)
November (3817)
December (2398)
Day
1 (201)
2 (206)
3 (190)
4 (155)
7 (259)
8 (192)
9 (186)
10 (134)
11 (155)
14 (165)
15 (161)
16 (146)
17 (144)
18 (119)
21 (173)
22 (170)
23 (154)
24 (127)
25 (109)
28 (188)
29 (164)
30 (151)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
7
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
Drug Development
Allos Therapeutics, Inc. Reports New Data Demonstrating that Responses to FOLOTYN are Correlated with Prolonged Survival in Patients with Relapsed or Refractory PTCL
June 7, 2010
·
1 min read
Business
Cornerstone Pharmaceuticals, Inc. Appoints Timothy Sullivan Executive Vice President and Head of Corporate Development
June 7, 2010
·
4 min read
Drug Development
Incyte Corporation Results from an Ongoing Phase I/II Trial of Oral INCB7839 Presented at American Society of Clinical Oncology
June 7, 2010
·
1 min read
Deals
Bio-Path Holdings, Inc. Signs Equity Financing Deal
June 7, 2010
·
1 min read
Biotech Bay
EPA Extends Asterand plc’'s Role in ToxCas(TM) Program
June 7, 2010
·
1 min read
Drug Development
AngioChem Presents Complete Phase 1 /2 Clinical Data for ANG1005: Further Demonstrating Benefits of Targeting LRP-1 Pathway in Cancer
June 7, 2010
·
1 min read
BioMidwest
GE Healthcare Helps Healthcare Providers Improve Patient Experience Through Innovative Technologies
June 7, 2010
·
1 min read
Drug Development
Harbor BioSciences, Inc. Apoptone(R) for Prostate Cancer Shows Activity at All Doses Tested
June 7, 2010
·
1 min read
Drug Development
Can-Fite BioPharma Announces Opening of CF101 Dermatology IND with Phase 2/3 Psoriasis Protocol
June 7, 2010
·
1 min read
Drug Development
Calistoga Pharmaceuticals’ CAL-101, an Oral Delta Isoform-Selective PI3K Inhibitor, Demonstrates Clinical Benefit in Patients with Relapsed or Refractory Indolent Non Hodgkin’s Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
June 7, 2010
·
1 min read
Previous
23 of 26
Next
